ArticleFrontiers in medicine2026

Tofacitinib combined with fire needle therapy for refractory cutaneous Rosai-Dorfman disease: a first case report and literature review.

Yuwen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.